A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/451 (2006.01) A61K 31/485 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2600350
The invention provides methods of attenuating, e.g., inhibiting or reducing, cellular proliferation and migration, particularly endothelial cell proliferation and migration, including that associated with angiogenesis, using opioid antagonists, including, but not limited to, those that are peripherally restricted antagonists.
L'invention concerne des procédés d'atténuation, par exemple, par inhibition ou réduction, de la prolifération et de la migration cellulaires, en particulier la prolifération et la migration des cellules endothéliales, y compris celles associées à l'angiogenèse, au moyen d'antagonistes opioïdes comprenant, de manière non exclusive, les antagonistes périphériquement restreints.
Garcia Joe G.n.
Lingen Mark
Moss Jonathan
Singleton Patrick A.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The University Of Chicago
LandOfFree
Use of opioid antagonists to attenuate endothelial cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of opioid antagonists to attenuate endothelial cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of opioid antagonists to attenuate endothelial cell... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1523072